Ligand Pharmaceuticals funds drug development in partnership with Merck.
1 report, 1 independent
Updated Aug 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Ligand Pharmaceuticals funds drug development in partnership with Merck.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Ligand Pharmaceuticals
biopharmaceutical company based out of La Jolla, California
-
Merck
public company in Indonesia
Related events
- Merck's stock price increased following positive drug performance involving Summit Therapeutics.
- Merck has set the list price for a drug that received approval from the FDA.
- Pfizer, Merck, and Amgen are large-cap drugmakers with significant operations in the United States.
- Ligand Pharmaceuticals received FDA approval for its drug Filspari and was listed on the Nasdaq stock exchange.
- Major pharmaceutical companies, including Pfizer, AstraZeneca, and Merck, announced several new partnerships and acquisitions in the oncology sector.